Apogee Therapeutics Inc.

Apogee Therapeutics Inc. focuses its clinical research on atopic dermatitis, with studies centered on patients with moderate-to-severe disease. The sponsor’s trial portfolio reflects sustained interest in both symptom control and longer-term treatment outcomes in this inflammatory skin disorder.

• Moderate-to-severe atopic dermatitis
• Skin inflammation
• Dermatologic disease management

The sponsor’s active studies examine effectiveness and long-term safety in the context of chronic dermatology care, with research activity distributed across multiple international sites.